| SANDOZ GROUP AG SF -,05 |
| Schweiz |
| Gesundheit |
| CH1243598427 / A3ETYB |
| D8Y (Frankfurt) |
| FRA:D8Y, ETR:D8Y, D8Y:GR |
| - |
| https://www.sandoz.com/ |
|
Sandoz Group AG is a Swiss company specializing in generic pharmaceuticals and biosimilars. It serves as the global leader in providing affordable generic and biosimilar medicines, with a purpose centered on pioneering access to treatments for patien..
>Volltext.. |
| 34624.86 Mio. EUR |
| 38952.85 Mio. EUR |
| 9760.3 Mio. EUR |
| 1979.62 Mio. EUR |
| 545.73 Mio. EUR |
| 1.26 EUR |
| 5299.76 Mio. EUR |
| 1067.98 Mio. EUR |
| 1598.58 Mio. EUR |
| 0.15 |
| 2.06% |
| 168.52% |
| 0.87 EUR |
| 1.09% |
| 1.09% |
| 13.04.26 - 0.8673081€ |
| - |
| SANDOZ |
| 23.08.26 |
|
||||
|
||||
|
||||
|
||||
|